Tag: life sciences
-

Genentech, Biotech Partner on Multiple Sclerosis
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech.
-

Trial to Test App Alerting for Dementia-Linked Drugs
A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial.
-

Trial Shows Immunotherapies Extend Life with Melanoma
First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers.
-

Crispr Enhanced for RNA Editing
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases.
-

Bacteria Recruited to Produce Graphene
Labs in the U.S. and the Netherlands developed techniques to sustainably produce high-quality graphene with more capabilities, using a strain of bacteria.
-

Analysis – Most New Drugs Not Adding Patient Benefits
An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care.
-

Voice Indicators to Monitor Dementia Progression
A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia.
-

Immunotherapy Biotech Gains $325M in Venture Funds
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round.
-

Blockchain Added to Clinical Trials Management
A contract research organization, or CRO, specializing in clinical trials is adding blockchain capability for data management, with help from an engineering consulting firm.
-

Start-Up Creating Blood Tests, Apps for Mental Disorders
A new enterprise based on psychiatric and molecular research at Indiana University is developing precision-medicine diagnostics for pain and mental disease.